Comment on: Pharmacokinetics and Safety of Recombinant Human Interleukin-1 Receptor Antagonist GR007 in Healthy Chinese Subjects
Crossref DOI link: https://doi.org/10.1007/s13318-019-00566-8
Published Online: 2019-06-26
Published Print: 2019-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Srinivas, Nuggehally R. http://orcid.org/0000-0002-5768-1332
Text and Data Mining valid from 2019-06-26
Version of Record valid from 2019-06-26
Article History
First Online: 26 June 2019
Compliance with Ethical Standards
:
: No funding was used to prepare this letter.
: The author has no conflict of interest.